diphenylamine has been researched along with Astrocytoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, MS; Fenster, T; Ilkhanizadeh, S; Jakobsson, J; Jandial, R; Martinez, M; Masic, S; Nicolaides, TP; Persson, AI; Petri, R; Sabelström, H; Sacheva, R; Saxena, S; Schmidt, C; Shchors, K; Snyder, EY; Weiss, WA; Yuan, E | 1 |
1 other study(ies) available for diphenylamine and Astrocytoma
Article | Year |
---|---|
Driving Neuronal Differentiation through Reversal of an ERK1/2-miR-124-SOX9 Axis Abrogates Glioblastoma Aggressiveness.
Topics: Animals; Astrocytoma; Benzamides; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Survival; Diphenylamine; Disease Progression; Female; Glioblastoma; Humans; Male; MAP Kinase Signaling System; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplastic Stem Cells; Neurogenesis; Neurons; Phenotype; Protein Kinase Inhibitors; Radiation Tolerance; SOX9 Transcription Factor | 2019 |